COVID-19 Impact on Global Neglected Tropical Diseases Drugs and Vaccine Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Malaria
  • 1.4.3 Ebola
  • 1.4.4 Dengue
  • 1.4.5 Chagas
  • 1.4.6 Leishmaniasis
  • 1.4.7 Other
• 1.5 Market by Application
  • 1.5.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2020 VS 2026
  • 1.5.2 Drugs
  • 1.5.3 Vaccines
• 1.6 Coronavirus Disease 2019 (Covid-19): Neglected Tropical Diseases Drugs and Vaccine Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Neglected Tropical Diseases Drugs and Vaccine Industry
    • 1.6.1.1 Neglected Tropical Diseases Drugs and Vaccine Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Neglected Tropical Diseases Drugs and Vaccine Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Neglected Tropical Diseases Drugs and Vaccine Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2015-2026)
• 2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Regions
  • 2.2.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Share by Regions (2015-2020)
  • 2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Neglected Tropical Diseases Drugs and Vaccine Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Neglected Tropical Diseases Drugs and Vaccine Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Market Size
  • 3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2015-2020)
  • 3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
  • 3.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2019
• 3.3 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
• 3.4 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
• 3.5 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2015-2020)
• 4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2021-2026)

5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application (2015-2026)

• 5.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)
• 5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
• 6.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in North America (2019-2020)
• 6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
• 6.4 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
• 7.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Europe (2019-2020)
• 7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
• 7.4 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

8 China

• 8.1 China Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
• 8.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in China (2019-2020)
• 8.3 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
• 8.4 China Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
• 9.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Japan (2019-2020)
• 9.3 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
• 9.4 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
• 10.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
• 10.4 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

11 India

• 11.1 India Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
• 11.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in India (2019-2020)
• 11.3 India Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
• 11.4 India Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size (2015-2020)
• 12.2 Neglected Tropical Diseases Drugs and Vaccine Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2015-2020)
• 12.4 Central & South America Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Artecef BV
  • 13.1.1 Artecef BV Company Details
  • 13.1.2 Artecef BV Business Overview and Its Total Revenue
  • 13.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
  • 13.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020))
  • 13.1.5 Artecef BV Recent Development
• 13.2 GlaxoSmithKline
  • 13.2.1 GlaxoSmithKline Company Details
  • 13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
  • 13.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
  • 13.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
  • 13.2.5 GlaxoSmithKline Recent Development
• 13.3 AstraZeneca
  • 13.3.1 AstraZeneca Company Details
  • 13.3.2 AstraZeneca Business Overview and Its Total Revenue
  • 13.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
  • 13.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
  • 13.3.5 AstraZeneca Recent Development
• 13.4 Novartis
  • 13.4.1 Novartis Company Details
  • 13.4.2 Novartis Business Overview and Its Total Revenue
  • 13.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
  • 13.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
  • 13.4.5 Novartis Recent Development
• 13.5 Sanofi-Aventis
  • 13.5.1 Sanofi-Aventis Company Details
  • 13.5.2 Sanofi-Aventis Business Overview and Its Total Revenue
  • 13.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
  • 13.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
  • 13.5.5 Sanofi-Aventis Recent Development
• 13.6 Ranbaxy Labs
  • 13.6.1 Ranbaxy Labs Company Details
  • 13.6.2 Ranbaxy Labs Business Overview and Its Total Revenue
  • 13.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
  • 13.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
  • 13.6.5 Ranbaxy Labs Recent Development
• 13.7 Lupin
  • 13.7.1 Lupin Company Details
  • 13.7.2 Lupin Business Overview and Its Total Revenue
  • 13.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
  • 13.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
  • 13.7.5 Lupin Recent Development
• 13.8 Macleods Pharmaceuticals
  • 13.8.1 Macleods Pharmaceuticals Company Details
  • 13.8.2 Macleods Pharmaceuticals Business Overview and Its Total Revenue
  • 13.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
  • 13.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
  • 13.8.5 Macleods Pharmaceuticals Recent Development
• 13.9 Cipla
  • 13.9.1 Cipla Company Details
  • 13.9.2 Cipla Business Overview and Its Total Revenue
  • 13.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
  • 13.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
  • 13.9.5 Cipla Recent Development
• 13.10 Romark Laboratories
  • 13.10.1 Romark Laboratories Company Details
  • 13.10.2 Romark Laboratories Business Overview and Its Total Revenue
  • 13.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
  • 13.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
  • 13.10.5 Romark Laboratories Recent Development
• 13.11 Toyama Chemica
  • 10.11.1 Toyama Chemica Company Details
  • 10.11.2 Toyama Chemica Business Overview and Its Total Revenue
  • 10.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
  • 10.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2015-2020)
  • 10.11.5 Toyama Chemica Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer